Elanco Animal Health SG&A Expenses 2016-2024 | ELAN

Elanco Animal Health sg&a expenses for the twelve months ending June 30, 2024 were $1.296B, a 1.33% increase year-over-year.

  • Elanco Animal Health annual sg&a expenses for 2023 were $1.285B, a 1.58% increase from 2022.
  • Elanco Animal Health annual sg&a expenses for 2022 were $1.265B, a 9.84% decline from 2021.
  • Elanco Animal Health annual sg&a expenses for 2021 were $1.403B, a 40.72% increase from 2020.

Elanco Animal Health SG&A Expenses 2016-2024 | ELAN

  • Elanco Animal Health annual sg&a expenses for 2023 were $1.285B, a 1.58% increase from 2022.
  • Elanco Animal Health annual sg&a expenses for 2022 were $1.265B, a 9.84% decline from 2021.
  • Elanco Animal Health annual sg&a expenses for 2021 were $1.403B, a 40.72% increase from 2020.
Related Stocks
Company NameMarket
Cap
Fresenius SE (FSNUY)$21.4B
Quest Diagnostics (DGX)$17.3B
DaVita (DVA)$13.7B
Encompass Health (EHC)$9.3B
Chemed (CHE)$8.7B
Option Care Health (OPCH)$5.3B
RadNet (RDNT)$5B
Amedisys (AMED)$3.2B
Astrana Health (ASTH)$2.8B
LifeStance Health (LFST)$2.6B
Addus HomeCare (ADUS)$2.4B
U.S Physical Therapy (USPH)$1.3B
Pennant (PNTG)$1.1B
Aveanna Healthcare Holdings (AVAH)$1B
Atai Life Sciences (ATAI)$208M
Daxor (DXR)$45M
ATI Physical Therapy (ATIP)$25M
MEDIROM Healthcare Technologies (MRM)$19M
Psychemedics (PMD)$14M
Ontrak (OTRK)$10M
Novo Integrated Sciences (NVOS)$6M
IMAC Holdings (BACK)$2M